Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/22/2866820/37414/en/Panbela-Therapeutics-Announces-Interim-Data-Analysis-for-ASPIRE-Trial-Pushed-to-Q1-2025.html
https://www.globenewswire.com/news-release/2024/04/18/2865349/37414/en/Panbela-Announces-Poster-Presentation-at-American-Association-for-Cancer-Research.html
https://www.globenewswire.com/news-release/2024/04/16/2864154/37414/en/Panbela-Announces-Transfer-to-OTCQB-Market.html
https://www.globenewswire.com/news-release/2024/03/26/2852750/37414/en/Panbela-Provides-Business-Update-and-Reports-Q4-and-FY-2024-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/12/2845035/37414/en/Panbela-to-Host-Fourth-Quarter-and-Year-End-2023-Earnings-Conference-Call-on-March-26-2024.html
https://www.globenewswire.com//news-release/2024/02/15/2829915/37414/en/Panbela-Regains-Compliance-with-Nasdaq-Listing-Standards-for-Bid-Price-and-Publicly-Held-Shares-Requirements.html
https://www.globenewswire.com//news-release/2024/02/01/2821839/37414/en/Panbela-Announces-Closing-of-Approximately-9-0-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2024/01/30/2819984/37414/en/Acceptance-of-Ivospemin-SBP-101-Abstract-for-Poster-Presentation-at-American-Association-for-Cancer-Research-AACR.html
https://panbela.com/wp-content/uploads/2024/01/PBLA-PR-Offering-2024-01-29.pdf
https://www.globenewswire.com//news-release/2024/01/25/2816570/37414/en/Panbela-Exceeds-50-Enrollment-for-Aspire-Trial-in-Pancreatic-Cancer-Exceeding-Anticipated-Timelines-with-Accelerated-Momentum.html